The European Patent Office published EP3856152A1, a patent application by Universität Heidelberg for methods of making oral dosage forms. The patent covers pharmaceutical compositions and manufacturing processes with IPC classifications including A61K 9/19, A61K 9/00, A61K 38/08, A61K 9/127, and A61K 47/64. The application names inventors UHL Philipp, SAUTER Max, and HAEFELI Walter-Emil, with designated states covering all 31 European patent member states including DE, FR, GB, IT, ES, NL, BE, CH, AT, SE, DK, FI, PL, and others.

Pharmaceutical companies and manufacturers developing oral dosage formulations should review this patent to assess potential freedom-to-operate implications or licensing opportunities. The patent grants exclusive rights to the applicant for the claimed manufacturing methods. No immediate compliance actions are required, but legal teams should monitor for opposition periods if relevant to product pipelines.